Senzime AB
6YC
Company Profile
Business description
Senzime AB, a medical technology company, develops, manufactures, and markets patient monitoring systems for monitoring patients. Its solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease healthcare costs. Its products include TetraGraph and TetraSens, ExSpiron, TetraSens Pediatric, and TetraConnect. Its geographical segments include Sweden, the United States of America which generates key revenue, Europe/Oceania, and Asia.
Contact
Ulls vag 41
Uppsala756 51
SWET: +46 18515640
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
52
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,148.90 | 93.60 | 1.16% |
| CAC 40 | 8,078.10 | 93.37 | -1.14% |
| DAX 40 | 22,899.07 | 388.99 | -1.67% |
| Dow JONES (US) | 41,767.38 | 197.25 | -0.47% |
| FTSE 100 | 8,689.37 | 17.29 | -0.20% |
| HKSE | 24,219.95 | 551.19 | -2.23% |
| NASDAQ | 17,672.21 | 78.58 | -0.44% |
| Nikkei 225 | 37,751.88 | 93.54 | -0.25% |
| NZX 50 Index | 12,054.72 | 8.79 | 0.07% |
| S&P 500 | 5,650.88 | 24.41 | -0.43% |
| S&P/ASX 200 | 7,918.90 | 90.60 | 1.16% |
| SSE Composite Index | 3,408.95 | 17.48 | -0.51% |